1H-1,2,3-Triazole-4,5-dicarbonitrile

Catalog No. :
ACZWLA051
CAS No. :
53817-16-6
Molecular Formula :
C4HN5
Molecular Weight :
119.09

IUPAC Name:1H-1,2,3-triazole-4,5-dicarbonitrile

1H-1,2,3-Triazole-4,5-dicarbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$65.00Login to see priceIn stockInquiry
250mg97%$106.00Login to see priceIn stockInquiry
1g97%$261.00Login to see priceIn stockInquiry
5g97%$993.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1H-1,2,3-Triazole-4,5-dicarbonitrile
IUPAC Name1H-1,2,3-triazole-4,5-dicarbonitrile
MDL No.MFCD13193135
Molecular FormulaC4HN5
Molecular Weight119.09
SMILESN#CC1=C(C#N)NN=N1
InChI KeyIVANFNGOSJTZFM-UHFFFAOYSA-N
Synonymdicyanotriazole | HDCTA | 4,5-Dicyano-2H-1,2,3triazole? | C4HN5 | 4,5-Dicyano-2H-1,2,3triazole | 4,5-dicyano-2h-1,2,3-triazole | AS-62813 | SCHEMBL1457382 | 2H-triazole-4,5-dicarbonitrile | 2H-1,2,3-triazole-4,5-dicarbonitrile | 4,5-dicyanotriazole | 1H-1
CAS No.53817-16-6
PubChem CID104614

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZWLA051 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZWLA051 route product structure diagram
    ACZWLA05153817-16-6 In Stock
Inquiry

2. ACZWLA051 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACZWLA051 route product structure diagram
    ACZWLA05153817-16-6 In Stock
Inquiry

Comments (0)